Patients need federally subsidized HIV testing and doctor’s visits if they participate in a free AIDS prevention program, the Presidential Advisory Council on HIV/AIDS said in a resolution Thursday.
The AIDS prevention program launched in December to give 200,000 uninsured patients access to Gilead Sciences Inc.'s Truvada, a daily pill that can help reduce the risk of contracting HIV. The free distribution of the drug is a cornerstone of the Trump administration’s initiative to reduce HIV infections. There were about 38,000 new cases of HIV in the U.S. in 2018, according to the Centers for Disease Control and Prevention.
Health ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.